Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Therapy for Pediatric Sickle Cell Disease Pain
NCT02536170Phase 2Completed
- Sponsor
- Emory University
- Start
- Feb 2016
- Primary completion
- Feb 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in sickle cell disease (SCD), sponsored by Emory University. Started Feb 2016; status: completed.
02
Drugs
arginine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02536170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536170.